Background Headache is a frequent symptom following COVID-19 immunization with a
typical onset within days post-vaccination. Cases of cerebral venous thrombosis (CVT) have …

Background Few studies have suggested a relationship between inflammation and cerebral
venous thrombosis (CVT). This retrospective study aimed to explore the changes in …

Septic thrombophlebitis (STP) is a complex, cross-disciplinary clinical condition that
combines a localized infection with a neighboring venous thrombosis. STP can occur at …

Background Cerebral venous thrombosis (CVT) is associated with intracranial hemorrhage.
Aim To identify clinical and imaging features of CVT-associated intracranial hemorrhage. We …

Background and purpose A prognostic score was developed to predict dependency and
death after cerebral venous thrombosis (CVT) to identify patients for targeted therapy in …

Abstract Background and Purpose Cerebral venous thrombosis (CVT) is a special
cerebrovascular disease that accounts for around 0.5%–1.0% of all strokes and often occurs …

Background and Purpose—Cerebral venous thrombosis (CVT) is rare in older patients. We
investigated whether clinical features and outcomes differ in older and younger patients …

Thrombotic Thrombocytopenia Syndrome (TTS) has emerged as a new adverse event
following immunization in individuals vaccinated with COVID-19 non-replicant adenovirus …

Antiphospholipid syndrome (APS) is a common autoimmune pro-thrombotic condition
characterised by thrombosis and pregnancy morbidity. There are a broad range of …

Abstract Background New Oral Anticoagulants (NOACs) such as Rivaroxaban are
introduced as alternatives to conventional vitamin-K antagonists in the long-term treatment …